Emtricitabine Capsule
Product Images NDC 69097-642

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Emtricitabine (NDC 69097-642). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (51787789 F222 42a1 B86b 8ca898722879 01)

FDA Label Image

Image (51787789 F222 42a1 B86b 8ca898722879 02)

FDA Label Image

30s Pack (51787789 F222 42a1 B86b 8ca898722879 03)

30s Pack (51787789 F222 42a1 B86b 8ca898722879 03)
This is a medication with the National Drug Code (NDC) 69097-642-02, consisting of 30 capsules for prescription use only. The medication contains Emtricitabine, with each capsule containing 200mg of this active ingredient, manufactured by Cipla. The medication should be stored between 15°C to 30°C (59°F to 86°F) and the USP Controlled Room Temperature of 25°C (77°F). Any additional information is not-readable.*
FDA Label Image

1000s Pack (51787789 F222 42a1 B86b 8ca898722879 04)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.